March 22 (Reuters) - Acorda Therapeutics Inc:
* Announces filing of patent extension applications for Ampyra(TM)
(dalfampridine)
* Says has applied to extend two Ampyra patents listed in the FDA Orange book
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Announces filing of patent extension applications for Ampyra(TM)
(dalfampridine)
* Says has applied to extend two Ampyra patents listed in the FDA Orange book
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.